← SynDRA
BML-257
SynDRA canonical compound SYN0086549 — structure-anchored drug synonym record
| Primary target(s) | AKT1 |
|---|
| Mechanism of action | HCV inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- AKT1 INHIBITOR
- HCV inhibitor
Cross-references
Synonyms
- 2,3-Diphenylquinoxaline-6-carboxylic acid
- RefChem:245139
- DTXCID60299135
- 2,3-Diphenyl-quinoxaline-6-carboxylic acid
- MFCD00555042
- CAY10567
- BML 257
- C21H14N2O2
- 2,3-Diphenyl-6-quinoxalinecarboxylic acid
- 6-Quinoxalinecarboxylic acid, 2,3-diphenyl-
- BiomolKI_000075
- ChemDiv1_026722
- BiomolKI2_000079
- Oprea1_542261
- Oprea1_641987
- CBDivE_011382
- MLS000554489
- DivK1c_004466
- orb1694053
- SCHEMBL6291531
- SCHEMBL30555665
- CHEBI:92563
- HMS662O14
- LFWGZXMTCUOPFI-UHFFFAOYSA-N
- 2,3-diphenyl-6-carboxyquinoxaline
- BDBM611673
- HMS2527N24
- US11718589, Compound 21b
- EBC-65147
- SBB016054
- STK500970
- AKOS000267817
- CCG-100679
- FD22514
- HY-W028714
- SDCCGSBI-0659526.P001
- CDS1_003426
- 2,3-diphenylquinoxaline-6-carboxylicacid
- NCGC00163391-01
Look up BML-257 in the interactive SynDRA portal →